{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:32:50Z","timestamp":1767969170040,"version":"3.49.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006345","name":"Uniwersytet Mikolaja Kopernika w Toruniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>At the beginning of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic, patients with inborn errors of immunity (IEI) appeared to be particularly vulnerable to a severe course of the disease. It quickly turned out that only some IEI groups are associated with a high risk of severe infection. However, data on the course of Coronavirus Disease 2019 (COVID-19) in patients with IEI are still insufficient, especially in children; hence, further analyses are required. The retrospective study included 155 unvaccinated people with IEI: 105 children and 50 adults (67.7% and 32.3%, respectively). Male patients dominated in the study group (94 people, 60.6%). At least two comorbidities were found in 50 patients (32.3%), significantly more often in adults (56% vs. 21%). Adult patients presented significantly more COVID-19 symptoms. Asymptomatic and mildly symptomatic course of COVID-19 was demonstrated in 74.8% of the entire group, significantly more often in children (88.6% vs. 46%). Moderate and severe courses dominated in adults (54% vs. 11.4%). Systemic antibiotic therapy was used the most frequently, especially in adults (60% vs. 14.3%). COVID-19-specific therapy was used almost exclusively in adults. In the whole group, complications occurred in 14.2% of patients, significantly more often in adults (30% vs. 6.7%). In the pediatric group, there were two cases (1.9%) of multisystem inflammatory syndrome in children. Deaths were reported only in the adult population and accounted for 3.9% of the entire study group. The death rate for all adults was 12%, 15.4% for adults diagnosed with common variable immunodeficiency, 12.5% for those with X-linked agammaglobulinemia, and 21.4% for patients with comorbidity. The results of our study imply that vaccinations against COVID-19 should be recommended both for children and adults with IEI. Postexposure prophylaxis and early antiviral and anti-SARS-CoV-2 antibody-based therapies should be considered in adults with IEI, especially in those with severe humoral immune deficiencies and comorbidity.<\/jats:p>","DOI":"10.3389\/fimmu.2022.953700","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T06:32:44Z","timestamp":1663914764000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["COVID-19 in unvaccinated patients with inborn errors of immunity\u2014polish experience"],"prefix":"10.3389","volume":"13","author":[{"given":"Sylwia","family":"Ko\u0142tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Zi\u0119tkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Grze\u015bk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"Becht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Berdej-Szczot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Cienkusz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena","family":"Ewertowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta","family":"Heropolita\u0144ska-Pliszka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Krysiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Lewandowicz-Uszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Mach-Tomalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Matyja-Bednarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Milchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Napi\u00f3rkowska-Baran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Pieniawska-\u015amiech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pituch-Noworolska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Renke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Roli\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Rywczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Stelmach-Go\u0142dy\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Strach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Suchanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Sulicka-Grodzicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Szczawi\u0144ska-Pop\u0142onyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Tokarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Wi\u0119sik-Szewczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Wolska-Ku\u015bnierz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Pac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.07.027","article-title":"Primary immunodeficiency diseases in COVID-19 pandemic: Apredisposing or protective factor","volume":"360","author":"Babaha","year":"2020","journal-title":"Am J Med Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e149459","DOI":"10.1172\/JCI149459","article-title":"Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19","volume":"131","author":"Cotsapas","year":"2021","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001062","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: Lessons learned","volume":"33","author":"Bucciol","year":"2021","journal-title":"CurrOpinPediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26424","article-title":"Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes","volume":"93","author":"Li","year":"2021","journal-title":"J Med Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00928-x","article-title":"Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency","volume":"41","author":"Delavari","year":"2021","journal-title":"J Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.09.010","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: An international study","volume":"147","author":"Meyts","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B8","unstructured":""},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for b cells in COVID-19? Lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01065-9","article-title":"COVID-19 in patients with primary immunodeficiency","volume":"41","author":"Esenboga","year":"2021","journal-title":"J Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01077-5","article-title":"COVID-19 in the context of inborn errors of immunity: A case series of 31 patients from Mexico","volume":"41","author":"Castano-Jaramillo","year":"2021","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1873767","article-title":"Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic","volume":"17","author":"Quinti","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"B13","first-page":"77","article-title":"COVID-19 in children with inborn errors of immunity: Clinical scenarios","volume":"10","author":"Moazzen","year":"2021","journal-title":"Am J Clin Exp Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108821","article-title":"COVID-19 in children and young adults with moderate\/severe inborn errors of immunity in a high burden area in pre-vaccine era","volume":"230","author":"Dey\u00e0-Mart\u00ednez","year":"2021","journal-title":"Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e13661","DOI":"10.1111\/pai.13661","article-title":"Clinical characteristics of COVID-19 in children and young adolescents with inborn errors of immunity","volume":"33","author":"Yilmaz Topal","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1515\/labmed-2015-0050","article-title":"Rational laboratory diagnostics of primary immunodeficiency disorders","volume":"39","author":"Haucka","year":"2015","journal-title":"J Lab Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01272","article-title":"The German national registry of primary immunodeficiencies (2012-2017)","volume":"19","author":"El-Helou","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/cei.12661","article-title":"The Swiss national registry for primary immunodeficiencies: Report on the first 6 years\u2019 activity from 2008 to 2014","volume":"182","author":"Marschall","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0556-1","article-title":"Fourth update on theIranian national registry of primary immunodeficiencies: Integration ofMolecular diagnosis","volume":"38","author":"Abolhassani","year":"2018","journal-title":"J Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837243","article-title":"The spectrum of inborn errors of immunity in the united Arab Emirates: 5 year experience in a tertiary center","volume":"13","author":"Shendi","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835770","article-title":"Risk factors for severe COVID-19 and hospital admission in patients with inborn errors of immunity - results from a multicenter nationwide study","volume":"13","author":"Milota","year":"2022","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01066-8","article-title":"Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: A cross-sectional study","volume":"41","author":"Goudouris","year":"2021","journal-title":"J Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.3390\/jcm10215111","article-title":"Assessment of COVID-19 incidence and the ability to synthesise anti-SARS-CoV-2 antibodies of paediatric patients with primary immunodeficiency","volume":"10","author":"Pieniawska-\u015amiech","year":"2021","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"uxac008","DOI":"10.1093\/cei\/uxac008","article-title":"Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK","author":"Shields","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e2116420","DOI":"10.1001\/jamanetworkopen.2021.16420","article-title":"Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2","volume":"4","author":"Payne","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jaip.2020.11.006","article-title":"COVID-19 infection in 10 common variable immunodeficiency patients in new York city","volume":"9","author":"Cohen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B27","volume-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines","year":"2022"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.953700\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T06:32:50Z","timestamp":1663914770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.953700\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2022.953700"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.953700","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"953700"}}